Kunugi S, Fukuda Y, Ishizaki M, Yamanaka N
Department of Pathology, Nippon Medical School, Tokyo, Japan. ShinobuHemmi/
Lab Invest. 2001 Sep;81(9):1309-18. doi: 10.1038/labinvest.3780344.
Matrix metalloproteinases (MMPs) have been implicated in the pathological processes of interstitial lung diseases. However, underlying mechanisms, particularly for activity levels and distribution of activated MMP-2 in the disease process, are yet to be elucidated. The present study investigated the immunolocalization of MMP-2, membrane type 1-matrix metalloproteinase (MT1-MMP), tissue inhibitor of metalloproteinase (TIMP)-2, p53, and Ki-67 in a rabbit model of bleomycin-induced pulmonary fibrosis. Gelatin zymography and in situ zymography were used to examine the activity and the localization of MMP-2. Furthermore, we performed Western blot and in situ hybridization for MT1-MMP, an activator for MMP-2. The total MMP-2 level estimated by gelatin zymography increased significantly at 3, 7, and 14 days after bleomycin administration, compared with controls. In the immunohistochemical study, immunoreaction for MMP-2 was strongest in alveolar epithelial cells among the cell populations. Swollen and/or elongated type II alveolar epithelial cells showed strong immunoreactions for MMP-2, MT1-MMP, and TIMP-2. After bleomycin administration, immunoreaction for p53 was observed in bronchiolar and alveolar epithelial cells. The proportion of p53-positive cells was high in epithelial cells from 1 to 14 days as MMP-2 levels were increased, suggesting that p53 may be responsible, at least in part, for the increase of MMP-2. The ratio of activated MMP-2 to total MMP-2 estimated by gelatin zymography increased significantly at 3, 7, 14, and 28 days after bleomycin treatment. In situ zymography revealed that type II alveolar epithelial cells degraded gelatin. An increased expression of MT1-MMP protein was observed by Western blot following administration of bleomycin. In situ hybridization demonstrated that type II alveolar epithelial cells gave intense signal for MT1-MMP mRNA. These results suggest that type II alveolar epithelial cells express MT1-MMP and activate MMP-2 on their cell surfaces, which may lead to the elongation and migration of alveolar epithelial cells in the repair process of bleomycin-induced pulmonary fibrosis.
基质金属蛋白酶(MMPs)与间质性肺疾病的病理过程有关。然而,其潜在机制,特别是疾病过程中活化MMP-2的活性水平和分布,尚待阐明。本研究在博来霉素诱导的兔肺纤维化模型中,研究了MMP-2、膜型1-基质金属蛋白酶(MT1-MMP)、金属蛋白酶组织抑制剂(TIMP)-2、p53和Ki-67的免疫定位。采用明胶酶谱法和原位酶谱法检测MMP-2的活性和定位。此外,我们对MMP-2的激活剂MT1-MMP进行了蛋白质印迹和原位杂交。与对照组相比,博来霉素给药后3、7和14天,通过明胶酶谱法估计的总MMP-2水平显著升高。在免疫组织化学研究中,MMP-2在细胞群体中的肺泡上皮细胞中免疫反应最强。肿胀和/或拉长的II型肺泡上皮细胞对MMP-2、MT1-MMP和TIMP-2表现出强烈的免疫反应。博来霉素给药后,在细支气管和肺泡上皮细胞中观察到p53的免疫反应。随着MMP-2水平的升高,1至14天上皮细胞中p53阳性细胞的比例较高,这表明p53可能至少部分地导致了MMP-2的增加。博来霉素治疗后3、7、14和28天,通过明胶酶谱法估计的活化MMP-2与总MMP-2的比率显著增加。原位酶谱显示II型肺泡上皮细胞降解明胶。博来霉素给药后,通过蛋白质印迹观察到MT1-MMP蛋白表达增加。原位杂交表明II型肺泡上皮细胞对MT1-MMP mRNA发出强烈信号。这些结果表明,II型肺泡上皮细胞在其细胞表面表达MT1-MMP并激活MMP-2,这可能导致博来霉素诱导的肺纤维化修复过程中肺泡上皮细胞的拉长和迁移。